Sacklers increases his bid to settle Purdue opioid cases, with new condition
Seven months after the Supreme Court struck a deal that would resolve thousands of opioid cases against Purdue Pharma, the company's owners, members of the Sackler family, increased their cash offer to resolve the litigation, but with a new problem.Under a new agreement, the Sacklers would not receive immunity from future opioid lawsuits, a condition they had long insisted on but which the court had ruled was impermissible.Instead, they would pay up to $6.5 billion – $500 million more than in the previous agreement – but with a new condition: Claimants, including states, municipalities and individuals, would have to set aside up to $800 million into an account similar to a legal account. -defense fund for billionaires to fight such cases, according to people familiar with the negotiation...










